Cc1nc(C)c(-c2csc(Nc3ccc(O)c(C(=O)O)c3)n2)s1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?